Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulconazole | 115221 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | sulconazole | 115221 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulconazole | 115221 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | sulconazole | 115221 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulconazole | 115221 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | sulconazole | 115221 | drug-path |
Asthma | R-HSA-444620 | map05310 | sulconazole | 115221 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | sulconazole | 115221 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | sulconazole | 115221 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulconazole | 115221 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulconazole | 115221 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | sulconazole | 115221 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulconazole | 115221 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | sulconazole | 115221 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | carbenoxolone | 636403 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | carbenoxolone | 636403 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | carbenoxolone | 636403 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | carbenoxolone | 636403 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | carbenoxolone | 636403 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | carbenoxolone | 636403 | drug-path |